Get latest articles and stories on Latest News at LatestLY. Syngene International Ltd on Thursday said it has signed a 10-year agreement with animal health company, Zoetis, to manufacture the drug substance for Librela which is used for treating osteoarthritis in dogs. Latest News | Syngene International, Zoetis to Manufacture Drug Treating Osteoarthritis in Dogs.
Syngene International Q1 profits up 33% yoy at ₹77 3 crore - The Hindu BusinessLine thehindubusinessline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindubusinessline.com Daily Mail and Mail on Sunday newspapers.